University of Texas M. D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center is one of the original 3 cancer treatment centers established after the 1971 National Cancer Act. It is a degree awarding institution and is connected to the University of Texas Medical Centers in Houston. Today the M.D. Anderson Cancer Center is one of the finest cancer treatment and research hospitals rivaled only by the Sloan-Kettering Cancer Center in New York. There are approximately 36 other cancer treatment centers designated by the National Cancer Institute as cancer centers. It is a 512 bed hospital with a Level 1 Trauma Center that employs over 17,000 professionals and support staff. The M.D. Anderson Cancer Center offers fellowships, internships and residency opportunities. The Center can trace its inception to 1941 by virtue of an act of the Texas Legislature.
Address
1515 Holcombe Blvd Unit 229, Houston, TX 77030
News Office
externalcomm [at] mdanderson [dot] org
Phone
713-792-0655
Fax
Web
http://www.mdanderson.org/departments/newsroom/dindex.cfm?pn=00c8a30f-c468-11d4-80fb00508b603a14
Contact
"University of Texas M. D. Anderson Cancer Center" in the news:
Detecting overall survival benefit derived from progression-free survival
Nov 10, 2009 |
not rated yet |
0
Overall survival (OS) may be a reasonable primary endpoint when the median survival postprogession (SSP) is less than 6 months, but it is too high a hurdle when SPP is longer than 12 months, according to a new study published ...
Green tea shows promise as chemoprevention agent for oral cancer, study finds
Nov 05, 2009 |
5 / 5 (1) |
0
Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer ...
Early-stage, HER2-positive breast cancer patients at increased risk of recurrence
Nov 02, 2009 |
not rated yet |
0
Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, ...
Th17 cells summon an immune system strike against cancer (w/ Video)
Oct 29, 2009 |
5 / 5 (1) |
0
A specific type of T helper cell awakens the immune system to the stealthy threat of cancer and triggers an attack of killer T cells custom-made to destroy the tumors, scientists from The University of Texas M. D. Anderson ...
Breast cancer patients with high risk gene diagnosed six years earlier than generation before
Oct 09, 2009 |
not rated yet |
0
Women with a deleterious gene mutation are diagnosed with breast cancer six years earlier than relatives of the previous generation who also had the disease and/or ovarian cancer, according to new research from The University ...
Study finds no relationship between PCR rate and race in women with breast cancer
Oct 09, 2009 |
not rated yet |
0
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same ...
KEAP1 Keeps major cancer-promoting protein at bay
Oct 09, 2009 |
5 / 5 (1) |
0
A tumor-suppressing protein snatches up an important cancer-promoting enzyme and tags it with molecules that condemn it to destruction, a research team led by scientists at The University of Texas M. D. Anderson ...
Although more older women receive breast-conserving therapy, gaps in treatment exist
Oct 09, 2009 |
not rated yet |
0
According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older ...
Researchers report benefits of new standard treatment study for rare pediatric brain cancer
Oct 09, 2009 |
not rated yet |
0
SAO PAULO, BRAZIL ― A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain ...
Stereotactic radiosurgery preferred method of treating cancer patients with brain metastases
Oct 06, 2009 |
5 / 5 (1) |
0
Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than ...
Texas begins $3 billion quest to cure cancer
Oct 02, 2009 |
not rated yet |
0
(AP) -- Texas gave birth to the modern oil industry, invented the handheld calculator and sent man to the moon. But can the Lone Star State cure cancer?
Women fare better than men with metastatic colorectal cancer -- are hormones helping?
Sep 29, 2009 |
not rated yet |
0
Younger women with metastatic colorectal cancer lived longer than younger men. However, this survival advantage disappeared with age, suggesting a benefit from estrogen or other hormones, according to results of a study published ...
Study examines use of toad venom in cancer treatment
Sep 24, 2009 |
not rated yet |
0
Huachansu, a Chinese medicine that comes from the dried venom secreted by the skin glands of toads, has tolerable toxicity levels, even at doses eight times those normally administered, and may slow disease progression in ...
Lung cancer suppresses miR-200 to invade and spread
Sep 14, 2009 |
5 / 5 (1) |
1
Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report ...
Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins
Sep 10, 2009 |
not rated yet |
0
While Fanconi anemia (FA) is a rare and dangerous disease, new laboratory research at The University of Texas M. D. Anderson Cancer Center shows it may lead researchers toward clues in more common diseases, including highly ...
